Log in to save to my catalogue

Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity

Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce5fbf4e53494c0aa92ecf91faad2632

Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity

About this item

Full title

Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (2), p.168

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The present experiment aimed to identify the potential protective role of empagliflozin (EMPA) on haloperidol (HAL)-induced ovarian damage in female rats because of its anti-inflammatory, antioxidant, and antiapoptotic effects. EMPA was administered in the presence and absence of HAL. Thirty-two adult female albino rats were divided into four group...

Alternative Titles

Full title

Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ce5fbf4e53494c0aa92ecf91faad2632

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce5fbf4e53494c0aa92ecf91faad2632

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph16020168

How to access this item